Who received the cash from the VIR share sales in the filing?

The cash proceeds are attributed to SVF Endurance (Cayman) Limited as the selling holder; the excerpt lists gross proceeds per trade. The filing does not state any company receipt of proceeds or use of proceeds.

SVF Endurance reports multiple VIR share sales

Q: What sales does the VIR Form 144 excerpt show?

The excerpt lists multiple sales by SVF Endurance (Cayman) Limited between 11/24/2025 and 02/11/2026. Each line shows a trade date, share count, and gross proceeds in dollars, e.g., 481,957 shares for $3,652,848.49.

Q: How large were the biggest sales reported in the excerpt for VIR?

Two of the largest reported trades are 481,957 shares on 01/23/2026 for $3,652,848.49 and 291,270 shares on 01/22/2026 for $2,146,543.39. Each trade line includes gross proceeds.

SVF Endurance (Cayman) Limited reported multiple open‑market sales of Common Stock of VIR.

Accepted by SEC EDGAR 02/25/2026 - 09:00 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

144

Rhea-AI Filing Summary

SVF Endurance (Cayman) Limited reported multiple open‑market sales of Common Stock of VIR. The filing lists individual transactions between 11/24/2025 and 02/11/2026 with per‑trade share counts and proceeds, including large blocks such as 481,957 shares on 01/23/2026 for $3,652,848.49 and 291,270 shares on 01/22/2026 for $2,146,543.39.

Insights

Routine resale activity by a single selling holder, detailed trade-by-trade.

The excerpt lists many discrete Common Stock transactions by SVF Endurance (Cayman) Limited dated between 11/24/2025 and 02/11/2026, each with a specific share count and gross proceeds in dollars. The record shows multiple sizable blocks sold on consecutive dates.

These entries are transactional disclosures rather than a company action; cash‑flow recipients are the selling holder. Subsequent filings or market prints would show whether additional dispositions occur.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What sales does the VIR Form 144 excerpt show?

The excerpt lists multiple sales by SVF Endurance (Cayman) Limited between 11/24/2025 and 02/11/2026. Each line shows a trade date, share count, and gross proceeds in dollars, e.g., 481,957 shares for $3,652,848.49.

How large were the biggest sales reported in the excerpt for VIR?

Two of the largest reported trades are 481,957 shares on 01/23/2026 for $3,652,848.49 and 291,270 shares on 01/22/2026 for $2,146,543.39. Each trade line includes gross proceeds.

What date range do the disclosed VIR trades cover in this excerpt?

The disclosed transactions span from 11/24/2025 through 02/11/2026. Each entry is dated and paired with the number of shares sold and the dollar amount received.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

144: Filer Information

Filer CIK

0001782338

Filer CCC

XXXXXXXX

Is this a LIVE or TEST Filing?

LIVE TEST

Submission Contact Information

Name

Phone

E-Mail Address

144: Issuer Information

Name of Issuer

Vir Biotechnology, Inc.

SEC File Number

001-39083

Address of Issuer

1800 Owens Street,
Suite 900,
San Francisco,
CALIFORNIA
94158

Phone

415-906-4324

Name of Person for Whose Account the Securities are To Be Sold

SVF Endurance (Cayman) Limited

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold

Name and Address of the Broker

Number of Shares or Other Units To Be Sold

Aggregate Market Value

Number of Shares or Other Units Outstanding

Approximate Date of Sale

Name the Securities Exchange

Common Stock

Citigroup Global Markets Inc.
388 Greenwich Street,
17th Floor
New York, NY 10013

400000

3796000.00

139517278

02/25/2026

NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class

Date you Acquired

Nature of Acquisition Transaction

Name of Person from Whom Acquired

Is this a Gift?

Date Donor Acquired

Amount of Securities Acquired

Date of Payment

Nature of Payment *

Common Stock

10/16/2019

Purchased in Issuer's initial public offering

Underwriters

950000

10/16/2019

Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller

Title of Securities Sold

Date of Sale

Amount of Securities Sold

Gross Proceeds